GA-68 DOTA-TOC

GA-68 DOTA-TOC · University of California, San Francisco

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GA-68 DOTA-TOC, covering 2019-11-12 to 2019-11-12. Get the full timeline:

Most recent: Clinical Trial Update: GA-68 DOTA-TOC of Somatostatin Positive Malignancies [Phase 1, Phase 2]